Ferro-Alloy Resources Limited (FAR) — Investment Research Note

Executive summary

Ferro-Alloy Resources is a pre-production vanadium developer whose principal asset is the giant Balasausqandiq deposit in southern Kazakhstan, alongside a small loss-making concentrate-processing plant that now functions mainly as an R&D centre. Across the 5-year period covered, the Group has steadily built out the feasibility study (US$932m NPV / 31% IRR per the Oct 2025 study plus the 2025 Chinese EPC revision), while existing operations have shrunk — H1 2026 revenue fell 28% YoY and the Group has material uncertainty around going concern given US$17.9m bonds versus US$0.8m cash. The single most important point for valuation today is that the project NPV is large relative to market cap (~£700m vs £31m) but requires US$312m of fresh capital against a balance sheet with negative equity (US$-1.5m) and 755m shares already in issue — so the equity story is dominated by massive future dilution risk, not current cash flows.

Fair value estimate

Methodology: Risk-adjusted NAV. Starting NPV8 of US$932m (CC6 revised, Oct 2025 feasibility study), deduct ~US$375m of financing cost (capex + contingency + 20% build/overhead buffer), apply a probability of successful execution of 25–35% (reflecting going-concern status, financing gap, Kazakh country risk, vanadium-price cyclicality, construction risk on a first-of-kind black-shale leach circuit).
Risked equity value: 0.30 × (US$932m − US$375m) ≈ US$167m ≈ £130m.
Dilution assumption: raising ~US$190m of fresh equity at an average 8–12p would require roughly 1.3–2.0bn additional shares, implying a diluted share count of ~2.1–2.8bn.
Fair value per share range: 4p – 9p, midpoint ~6p.
Implied market cap range (current share count basis): £30m – £68m, midpoint ~£45m.
Current market cap: £31.3m. Absolute upside to midpoint: ~+45% (range: approx. –3% to +117%).
Note: the project NPV is denominated in US$ and reported in company filings in US$; translated to GBP at ~1.33 for this note.

Sector context

Confirmed sector: Basic Resources / Basic Materials (metals & mining, developer-stage).
Quality/leverage profile is well below typical sector peers: pre-revenue at project level, negative equity, bond maturities concentrated in 2026-27, repeated going-concern paragraphs.
Listed peer references: Largo Inc. (TSX/NYSE), Bushveld Minerals (previously AIM, now suspended), Technology Metals Australia. All have struggled over the past 3 years with vanadium prices; most trade on heavily discounted NAV with similar execution/financing risks.

Investment thesis (3 bullets)

Potentially one of the lowest-cost vanadium operations globally once built — black-shale ore avoids pre-concentration and roasting, giving a cash cost of US$4.35/lb pre-credits and US$0.36/lb after by-product credits (feasibility study, Oct 2025). Multiple by-product optionality: carbon black substitute (247kt/yr), uranium, molybdenum, yttrium/REEs. 2026-04 2025 Final Results; 2026-07 Strategic Update
Rare-earth and US-critical-minerals optionality is a real, free call option. Historical assays indicate ~100 g/t yttrium plus other REEs; the Company estimates c.US$4.57bn of in-situ yttrium value over 20 years before recoveries. Engagement with a US Government financing institution and a California REE-separation partner (Maglut) provides a path to non-dilutive capital. 2026-07 Strategic Update; 2026-09 interim results
New CEO Peter Secker brings credible build/finance experience — five greenfield mines commissioned, >US$2bn raised in prior roles — alongside continued cornerstone support from Vision Blue (Sir Mick Davis as chair). This materially de-risks execution relative to a founder-only team. 2026-07 Strategic Update

Key risks (3 bullets)

Going concern / near-term liquidity. Auditor flagged material uncertainty for both FY24 and FY25. US$12.6m of bonds (Tranches 1-3) matured through 2026; a US$5.7m July 2026 placing repaid Tranches 1 and 3 at the cost of 167.6m new shares — a ~30% share-count increase in a single tranche. Tranche 4 of US$5m remains outstanding to Nov 2027. 2026-09 interim; 2026-04 2025 Final Results
Enormous financing gap vs market cap. Project needs US$312m of fresh capital against a Company that could not raise more than US$5.7m in a single tranche in 2026. Any debt-dominant structure (DFC, EDC, etc.) still requires a substantial equity sliver, implying 1-2bn new shares. 2026-04 2025 Final Results
Commodity-price and timing cyclicality. The project IRR of 22-31% is calculated against CRU's long-term vanadium price curve (US$8-10/lb). The spot price has repeatedly moved in a 2-3× range through the period; existing operations swung from profitable in 2022-23 to loss-making in 2024-26 on this. 2024-12 Trading Update; 2023-08 Trading Update

Operating leverage

Analysis is bifurcated. The existing plant has a reasonably high fixed-cost share (depreciation + fixed labour + overhead ~40-45% of total costs when the plant is running at design throughput) and clearly displays operating leverage — Q2 2022 and Q1 2026 produced step-change improvements in gross margin when concentrate supply unlocked. But absolute scale is tiny: US$1.8m revenue in H1 2026 vs US$1.6m fixed admin + depreciation per half, so even 50% revenue uplift would only halve the gross loss. The Balasausqandiq project is where real operating leverage sits: cash cost of US$0.36/lb net of by-products against CRU's US$8-10/lb forecast means contribution margins approaching 90-95% at steady state, with 8,500t annual V₂O₅ production implying EBITDA of ~US$150-170m against capex of US$312m. A 10-20% revenue beat at steady state would plausibly more than double EBITDA from the base case. However, this leverage only crystallises if and when construction, commissioning and ramp-up succeed — none of which can be assumed from today's balance-sheet position.

Value-trap signals

Repeated feasibility-study timing slips: originally H1 2023 → H1 2024 → Q4 2024 → finally published Oct 2025. multiple interim releases
Declining revenue trend at the existing plant: FY22 US$6.3m → FY23 US$5.7m → FY24 US$4.7m → FY25 US$4.5m → H1 2026 US$1.8m (annualised US$3.6m).
Negative shareholders' equity: US$(2.7m) at 31 Dec 2025, US$(1.5m) at 30 Jun 2026.
Serial dilution: shares outstanding 377m (end-2021) → 483m (end-2024) → 755m (post Jul-2026 placing). ~2× dilution in five years with no production uplift to match.
Audit emphasis-of-matter paragraphs in both FY24 and FY25.
Kazakhstan regulatory risk: Subsoil Use Agreement obligations repeatedly deferred; auditor flagged this as a key judgement area.

Earnings vs expectations

Management does not provide formal production or revenue guidance in a form that permits a strict beat/meet/miss comparison, but qualitative directional guidance has been consistently missed. The Dec 2023 trading update was itself a profit warning citing prices and concentrate throughput shortfalls versus prior commentary. The Sep 2024 interim results delivered revenue of US$2.1m versus a prior "H2 significantly higher than H1" promise that did not materialise. Feasibility study publication slipped by ~18 months. Pattern: more misses than beats, with the business consistently delivering below the pacing implied by management narrative, driven by both external factors (vanadium prices, concentrate supply) and internal execution.

Conviction

Conviction: 2 (low). The fair-value estimate is a wide range anchored on a feasibility-study NPV that is sensitive to a vanadium price assumption that has already proven volatile through the review period, a probability-of-success guess (25-35%) that is itself a judgement call, and a dilution factor that depends on the ultimate equity/debt split and share price at which capital is raised.

Anchors (supporting confidence): the Oct 2025 SRK/Tetra Tech feasibility study is externally produced and independently verifiable; two separate EPC estimates (Chinese and in-study) bracket the capex; the geology and metallurgy are well-defined after 20+ years of pilot work.
Caveats (limiting confidence): going-concern uncertainty makes the equity more an option than a going-concern valuation; dilution path is highly path-dependent; vanadium long-term price is CRU's forecast, not a market-observable curve.

Driver scoring

ai_beneficiary 5 — This is a vanadium miner. Vanadium flow batteries have a very loose link to data-centre energy storage, but FAR is a pre-production developer with no AI customer, no AI-driven revenue line, and no demonstrable productivity moat. Press-release AI mentions: zero. Pure commodity exposure.
operating_leverage 55 — Mixed. The existing plant has limited leverage at scale. The project, if built, has very high leverage (90%+ contribution margins). Weighted probabilistically, around 55.
earnings_surprise_trend 25 — Pattern of missed timing on feasibility study, missed H2 outcomes, and declining revenue vs prior directional commentary.
cyclicality 90 — Pure commodity (vanadium, moly, nickel) exposure. Deeply cyclical.
moat 35 — The low cost-curve position of Balasausqandiq would be a genuine moat if built; today, there is no operating moat. Mid-30s reflects the latent advantage weighted by execution risk.
leverage 75 — US$17.9m of bonds against negative equity, going concern uncertainty, further dilutive capital needs. Not quite distressed (recent raises have cleared near-term bonds) but clearly in the 2-4x+ EBITDA-equivalent band.
earnings_quality 30 — Losses throughout the period, aggressive capitalisation of feasibility costs, going-concern qualifiers, repeated subsoil deferrals treated as judgement rather than contingency.
management_quality 50 — Long tenure of founder-CEO is a mixed signal; feasibility study delivery is a tick; chronic missed timing is a cross. New CEO brings credible build credentials.
growth_momentum 25 — Existing plant revenue declining; project NPV is prospective, not current growth.

`overall_score` 90 / 1000

This stock is a poor fit for the stated investor profile. It is a commodity-cycle, pre-production developer with zero AI-receiver exposure, a stretched balance sheet with going-concern language, and valuation that — while potentially cheap on a risked-NPV basis — is not available at a price that offers downside protection. The upside case requires several things to go right in sequence (financing, construction, vanadium price, ramp-up). This is an interesting speculation for a resource specialist, not a stock for a portfolio built around AI beneficiaries with valuation discipline and downside protection.